COVID Vaccinations are Causing Signs of Parkinson’s Disease and Other Neurological Diseases, According to a Scientist

(Children’s Health Defense) – July 22, 2021 Scientists are issuing urgent warnings about a possible tsunami of other types of neurological injuries as cases of the reportedly “rare” neurological disorder Guillain-Barré syndrome in people who received a COVID vaccine mount (445 as of July 9) — forcing the sluggish US Food and Drug Administration (FDA) to add a warning label to the Johnson & Johnson (J&J) shot.

In February, immunologist J. Bart Classen, a former NIH contract scientist and owner of Classen Immunotherapies, a Maryland biotechnology firm, presented a paper describing the potential for messenger RNA (mRNA) COVID vaccinations to stimulate development.

Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender

Classen has now published a second article on the dangers of prion disease, this time based on real-world data from the United Kingdom following vaccination with the AstraZeneca or Pfizer COVID vaccines.

The risk of neurodegenerative adverse outcomes is far from theoretical, according to these findings. In fact, the AstraZeneca vaccination for Parkinson’s disease is already delivering a safety signal, and the Pfizer vaccine may not be far behind.

The signal is clear.
Classen’s research focuses on six months of data (until mid-June 2021) for two of the experimental COVID injections that are now approved in the United Kingdom.

The data is organized by organ system and symptom or disease in the UK government’s Yellow Card adverse event reporting system.

Despite the fact that both vaccines attempt to stimulate the development of coronavirus spike protein and associated antibodies in the recipient, Classen says the two injections are “very distinct in their content.”

This could explain the first startling result of Classen’s examination of adverse reaction data: In comparison to the Pfizer injection, the AstraZeneca injection has had 3.55 times higher adverse events reported in the United Kingdom (745,965 vs. 210,168). Each AstraZeneca report included an average of 3.63 adverse responses, compared to 2.84 adverse reactions for each of the other companies.

This pattern holds true for “Nervous Disorders,” with 4.14 times as many reported for the AstraZeneca shot versus the Pfizer shot (statistically significant at the p=0.00001 level).

Parkinson’s disease reactions show a “very significant and specific rise… in the AstraZeneca reports compared to the Pfizer vaccination data” in the “Nervous Disorders” category.

The following are statistically significant findings:

There were 185 Parkinson’s reactions reported after AstraZeneca vaccination against 20 after Pfizer injections (mostly due to a symptom named “Freezing Phenomenon”).

This pattern holds true for “Nervous Disorders,” with 4.14 times as many reported for the AstraZeneca shot versus the Pfizer shot (statistically significant at the p=0.00001 level).

Parkinson’s disease reactions show a “very significant and specific rise… in the AstraZeneca reports compared to the Pfizer vaccination data” in the “Nervous Disorders” category.

The following are statistically significant findings:

There were 185 Parkinson’s reactions reported after AstraZeneca vaccination against 20 after Pfizer injections (mostly due to a symptom named “Freezing Phenomenon”).

AstraZeneca and Pfizer had 9,288 and 937 reports of tremor (another probable Parkinson’s sign), respectively, and 58 and 4 reports of sleep difficulties (a hallmark symptom of a prion illness called “fatal familial insomnia”).
Classen describes the findings as a “clear indicator of a specific prion disease, Parkinson’s disease,” noting that they are scientifically feasible given what is known about the pathogenic coronavirus spike protein.
Furthermore, the hallmark symptoms of freezing, tremor, and sleep problems are consistent with the “well established pathophysiology of prion disease.”

Is it possible that the sickness is progressing more quickly?
Normally, experts assume that aberrant protein folding takes years (or perhaps decades) to cause prion disease. So how did Classen spot a “clear signal” for Parkinson’s disease merely months after the vaccines went on the market?

Classen proposes a number of explanations, none of which are mutually incompatible. First, he claims that COVID vaccines may hasten disease progression in people who have either preclinical prion disease or mild prion illness that hasn’t been correctly recognized.

Furthermore, there is evidence that the vaccination spike protein can cause critical RNA/DNA binding proteins to misfold.

COVID vaccines aren’t the only ones that have a negative impact on the neurological system. Symptoms that are considered warning flags for neurological issues abound among the approximately 400 adverse events described in the package inserts for U.S. youth immunizations. Dizziness, headaches, numbness, balance problems, muscle weakness, paralysis, seizures, vision abnormalities, poor sleep, and tremors are some of the symptoms.

And, long before COVID-19, at least 20 other vaccines’ inserts included Guillain-Barré syndrome (a condition in which the immune system assaults the nerves) as an adverse event recorded in clinical trials or after the vaccine was released.

Guillain-Barré syndrome causes weakness, tingling, and paralysis in certain people, but it also causes death in 4% to 7% of cases. In mid-July, the FDA reluctantly added a Guillain-Barré warning for the J&J COVID-19 vaccine, letting the public know that certain COVID vaccination recipients can expect catastrophic or fatal neurological effects.

FDA will announce new warning on J&J's COVID vaccine saying shot has been linked to Guillain–Barré syndrome, a “serious but rare” autoimmune disorder.

SUBSCRIBE #TheDefender: https://t.co/zL66Edfiw5https://t.co/6EQh4eNj7d

— Robert F. Kennedy Jr (@RobertKennedyJr) July 13, 2021